Vanta Labs HGH Fragment 176-191 2mg research vial on a white background

HGH Fragment 176-191

2mg
£22.50
Sale price  £22.50 Regular price 
Skip to product information
Vanta Labs HGH Fragment 176-191 2mg research vial on a white background

HGH Fragment 176-191

£22.50
Sale price  £22.50 Regular price 
Size

HGH Fragment 176-191

HGH Fragment 176-191 is a synthetic peptide corresponding to amino acids 176–191 of the C-terminal region of human growth hormone (hGH), a 16-amino acid sequence that encompasses the lipolytic domain of the GH molecule. It was developed by researchers at Monash University as part of a programme to isolate the fat-metabolising activity of GH from its growth-promoting and diabetogenic effects. HGH Fragment 176-191 retains the lipolytic potency of full-length GH while lacking significant activity at the GH receptor (GHR) for IGF-1 stimulation or insulin resistance induction, making it a selective research tool for studying GH-mediated lipolysis and adipose tissue metabolism.

Mechanism of Action

HGH Fragment 176-191 exerts its lipolytic effects through a mechanism that is distinct from classical GHR-mediated signalling. Unlike full-length GH, which activates the GHR/JAK2/STAT5 pathway to stimulate IGF-1 production and promote growth, HGH Fragment 176-191 does not bind the GHR with significant affinity and does not stimulate IGF-1 secretion. Instead, it is proposed to act via a β-adrenergic-like mechanism, stimulating adenylyl cyclase and cAMP production in adipocytes, which activates hormone-sensitive lipase (HSL) and promotes triglyceride hydrolysis and fatty acid release. It also inhibits lipogenesis by reducing the activity of fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC), providing a dual mechanism of lipolysis stimulation and lipogenesis inhibition in adipose tissue research models.

Research Applications

  • GH lipolytic domain pharmacology and adipocyte lipolysis mechanism studies
  • Hormone-sensitive lipase (HSL) activation and triglyceride hydrolysis research
  • Lipogenesis inhibition, fatty acid synthase (FAS), and ACC regulation investigation
  • Adipose tissue metabolism, body composition, and fat mobilisation preclinical models
  • GH fragment biology and structure-activity relationship (SAR) research

Specifications

  • Molecular Formula: C₇₈H₁₂₃N₂₃O₂₂S₂
  • Molecular Weight: 1817.1 g/mol
  • CAS Number: 66004-57-7
  • Purity: ≥98%
  • Form: Lyophilised powder
  • Storage: -20°C
  • Shelf Life: 24 months

This product is intended for legitimate laboratory and analytical research use only. Not for human use, veterinary use, or consumer use. Not for diagnostic or therapeutic purposes.

Related Products

Product Specifications

Purity ≥98%
Molecular Weight 1817.1 g/mol
CAS Number 66004-57-7
Molecular Formula C₇₈H₁₂₃N₂₃O₂₂S₂
Form Lyophilised powder
Storage Temperature -20°C
Shelf Life 24 months